Long-Term Follow-up of the Efficacy and Safety of Ponatinib in Philadelphia Chromosome-Positive Leukemia Patients with the T315I Mutation
Year: 2016
Type: article
Source: Blood
Authors: Elias J. Jabbour, Jorge E. Cortes, Moshe Talpaz, Michele Baccarani, Michael J. Mauro, Andreas Hochhaus, Timothy P. Hughes, Francois Guilhot, Michael W. Deininger, Neil Shah, Dale L. Bixby, Ian W. Flinn, Thomas O'Hare, Stephanie Lustgarten, Victor M. Rivera, Sergio Santillana, Hagop M. Kantarjian
Institutions: The University of Texas MD Anderson Cancer Center, University of Michigan, IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola, University of Bologna, Memorial Sloan Kettering Cancer Center, Jena University Hospital, South Australian Health and Medical Research Institute, The University of Adelaide, Inserm, Centre Hospitalier Universitaire de Poitiers, Huntsman Cancer Institute, University of California, San Francisco, Sarah Cannon, ARIAD Pharmaceuticals (United States)
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2594958377